Skip to main content

Table 1 Clinical characteristics of the SLE patients at the time point of blood sampling

From: Protein synthesis of the pro-inflammatory S100A8/A9 complex in plasmacytoid dendritic cells and cell surface S100A8/A9 on leukocyte subpopulations in systemic lupus erythematosus

Characteristics SLE (n= 63) Control (n= 33)
Age, median (range), years 42 (19 to 81) 45 (24 to 79)
Female, % 94 85
Male, % 6 15
Disease duration, median (range), years 8 (0 to 45) -
SLEDAI score, median (range) 2 (0 to 18) -
Seizure 0 -
Psychosis 0 -
Organic brain syndrome 0 -
Visual disturbance 1 -
Cranial nerve disorder 1 -
Lupus headache 0 -
Cerebrovascular accident 0 -
Vasculitis 3 -
Arthritis 8 -
Myositis 1 -
Kidney involvement (urinary cast, hematuria, proteinuria or pyuria) 14 -
Mucocutaneous activity (rash, alopecia or mucosal ulcers) 12 -
Pleurisy 0 -
Pericarditis 0 -
Low complement (C3 or C4) 14 -
Anti-DNA antibodies 14 -
Fever 2 -
Thrombocytopenia 1 -
Leukopenia 2 -
  1. Items included in SLE disease activity (SLEDAI) are shown.